Effects of ghrelin on homocysteine-induced dysfunction and inflammatory response in rat cardiac microvascular endothelial cells

Cell Biology International

Volumn 36, Issue 6, 2012, Pages 511-517

  Wang, Dongjuan ^a   Wang, Haichang ^a   Luo, Peng ^a   Hwang, Andrew ^b   Sun, Dongdong ^a   Wang, Yabin ^a   Zhang, Zheng ^a   Liu, Nan ^a   Wang, Shenxu ^a   Li, Chengxiang ^a   Cao, Feng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac microvascular endothelial cell (CMEC); Ghrelin; Homocysteine (HCY); Inflammatory response; NF B

Indexed keywords

CASPASE 3; CELL ADHESION MOLECULE; CYCLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GHRELIN; HOMOCYSTEINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; ENZYME MODIFICATION; HEART MUSCLE CELL; INFLAMMATION; MALE; MICROVASCULAR ENDOTHELIAL CELL; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CASPASE 3; CELL PROLIFERATION; CELLS, CULTURED; CORONARY VESSELS; CYTOKINES; ENDOTHELIAL CELLS; GHRELIN; HOMOCYSTEINE; INFLAMMATION MEDIATORS; MALE; MICROVESSELS; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84862489081     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20110235     Document Type: Article

References (36)

1. Avogaro A, Giorda C, Maggini M, Mannucci E, Raschetti R, Lombardo F et al. Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location. Diabetes Care. 2007;30:1241-7.
2. Cheung GT, Siow YL, O K. Homocysteine stimulates monocyte chemoattractant protein-1 expression in mesangial cells via NFkappaB activation. Can J Physiol Pharmacol. 2008;86:88-96.
3. de Ruijter W, Westendorp RG, Assendelft WJ, den Elzen WP, de Craen AJ, le Cessie S et al. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. Br Med J 2009;338:a3083.
4. Dinckal MH, Aksoy N, Aksoy M, Davutoglu V, Soydinc S, Kirilmaz A et al. Effect of homocysteine-lowering therapy on vascular endothelial function and exercise performance in coronary patients with hyperhomocysteinaemia. Acta Cardiol 2003;58:389-96.
5. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA, Jr. et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999;398:718-23.
6. Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 2006;25:6680-4.
7. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002;87:2988.
8. Hedayati N, Annambhotla S, Jiang J, Wang X, Chai H, Lin PH et al. Growth hormone-releasing peptide ghrelin inhibits homocysteineinduced endothelial dysfunction in porcine coronary arteries and human endothelial cells. J Vasc Surg 2009;49:199-207.
9. Huda MS, Durham BH, Wong SP, Deepak D, Kerrigan D, McCulloch P et al. Plasma obestatin levels are lower in obese and postgastrectomy subjects, but do not change in response to a meal. Int J Obes (Lond) 2008;32:129-35.
10. Iantorno M, Chen H, Kim JA, Tesauro M, Lauro D, Cardillo C et al. Ghrelin has novel vascular actions that mimic PI 3-kinasedependent actions of insulin to stimulate production of NO from endothelial cells. Am J Physiol Endocrinol Metab. 2007;292:E756-64.
11. Isgaard J, Barlind A, Johansson I. Cardiovascular effects of ghrelin and growth hormone secretagogues. Cardiovasc Hematol Disord Drug Targets 2008;8:133-7.
12. Kanaji N, Sato T, Nelson A, Wang X, Li Y, Kim M et al. Inflammatory cytokines regulate endothelial cell survival and tissue repair functions via NF-kappaB signaling. J Inflamm Res. 2011;4:127-38.
13. Kang S, Yang Y. Coronary microvascular reperfusion injury and noreflow in acute myocardial infarction. Clin Invest Med 2007;30:E133-45.
14. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-60.
15. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev 2005;85:495-522.
16. Li WG, Gavrila D, Liu X, Wang L, Gunnlaugsson S, Stoll LL et al. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation. 2004;109:2221-6.
17. McDowell IF, Lang D. Homocysteine and endothelial dysfunction: a link with cardiovascular disease. J Nutr 2000;130:369S-72S.
18. Moat SJ, Lang D, McDowell IF, Clarke ZL, Madhavan AK, Lewis MJ et al. Folate, homocysteine, endothelial function and cardiovascular disease. J Nutr Biochem 2004;15:64-79.
19. Nagaya N, Uematsu M, Kojima M, Ikeda Y, Yoshihara F, Shimizu W et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001;104:1430-5.
20. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol 1998;18:842-51.
21. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K et al. A role for ghrelin in the central regulation of feeding. Nature 2001;409:194-8.
22. Nam NH. Naturally occurring NF-kappaB inhibitors. Mini Rev Med Chem 2006;6:945-51.
23. Nishida M, Carley WW, Gerritsen ME, Ellingsen O, Kelly RA, Smith TW. Isolation and characterization of human and rat cardiac microvascular endothelial cells. Am J Physiol Heart Circ Physiol 1993;264:H639-52.
24. Oudi ME, Aouni Z, Mazigh C, Khochkar R, Gazoueni E, Haouela H et al. Homocysteine and markers of inflammation in acute coronary syndrome. Exp Clin Cardiol 2010;15:e25-8.
25. Ozbay Y, Aydin S, Dagli AF, Akbulut M, Dagli N, Kilic N et al. Obestatin is present in saliva: alterations in obestatin and ghrelin levels of saliva and serum in ischemic heart disease. BMB Rep 2008;41:55-61.
26. Pasterkamp G, Algra A, Grobbee DE, de Jaegere PP, Banga JD, van der Graaf Y. Homocysteine and the stage of atherosclerotic disease: a study in patients suffering from clinically silent and clinically manifest atherosclerotic disease. Eur J Clin Invest. 2002;32:309-15.
27. Schnyder G, Flammer Y, Roffi M, Pin R, Hess OM. Plasma homocysteine levels and late outcome after coronary angioplasty. J Am Coll Cardiol 2002;40:1769-76.
28. Shai I, Stampfer MJ, Ma J, Manson JE, Hankinson SE, Cannuscio C et al. Homocysteine as a risk factor for coronary heart diseases and its association with inflammatory biomarkers, lipids and dietary factors. Atherosclerosis 2004;177:375-81.
29. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407:908-13.
30. Wang G, Woo CW, Sung FL, Siow YL, O K. Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia: role of chemokine and adhesion molecules. Arterioscler Thromb Vasc Biol 2002;22:1777-83.
31. Wang Y, Narsinh K, Zhao L, Sun D, Wang D, Zhang Z et al. Effects and mechanisms of ghrelin on cardiac microvascular endothelial cells in rats. Cell Biol Int 2010;35:135-40.
32. Wei L, Sun D, Yin Z, Yuan Y, Hwang A, Zhang Y et al. A PKC-beta inhibitor protects against cardiacmicrovascular ischemia reperfusion injury in diabetic rats. Apoptosis. 2010a;15:488-98.
33. Wei L, Yin Z, Yuan Y, Hwang A, Lee A, Sun D et al. A PKC-beta inhibitor treatment reverses cardiac microvascular barrier dysfunction in diabetic rats. Microvasc Res 2010b;80:158-65.
34. Xu X, Jhun BS, Ha CH, Jin ZG. Molecular mechanisms of ghrelinmediated endothelial nitric oxide synthase activation. Endocrinology 2008;149:4183-92.
35. Xu XB, Pang JJ, Cao JM, Ni C, Xu RK, Peng XZ et al. GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure. Am J Physiol Heart Circ Physiol 2005;289:H1643-51.
36. Zhang D, Jiang X, Fang P, Yan Y, Song J, Gupta S et al. Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice. Circulation 2009;120:1893-902.